Stalled oligodendrocyte differentiation in IDH-mutant gliomas

ConclusionsOur studies show that despite differences in clinical manifestation and genomic alterations, all IDH-mutant gliomas resemble early stages of oligodendrocyte lineage and are stalled in oligodendrocyte differentiation due to blocked myelination program. These findings provide a framework to accommodate biological features and therapy development for IDH-mutant gliomas.
Source: Genome Medicine - Category: Genetics & Stem Cells Source Type: research